Overview
Pallavi Srivastava practices practicing medicine in Greater Noida, India.
Ms. Srivastava is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Toxic Megacolon, Intraductal Papilloma, Gallbladder Disease, Tissue Biopsy, and Orchiectomy.
She is actively involved in clinical research, co-authoring 40 peer reviewed articles.
Gender
Locations
Lucknow, UP 226010, India
Manohar, UP, India
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Pallavi Srivastava
Is Pallavi Srivastava a top-rated expert for Toxic Megacolon?
MediFind is an objective health platform that identifies experts based on real-world data. Pallavi Srivastava is classified as an Advanced expert for Toxic Megacolon, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Pallavi Srivastava participate in research or clinical trials?
Yes. Pallavi Srivastava has published 40 articles and abstracts on conditions like Toxic Megacolon. You can view a list of Pallavi Srivastava's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Intraductal PapillomaMs. Srivastava isAdvanced. Learn about Intraductal Papilloma.
- Toxic MegacolonMs. Srivastava isAdvanced. Learn about Toxic Megacolon.
- Experienced
- AmebiasisMs. Srivastava isExperienced. Learn about Amebiasis.
- Amebic Liver AbscessMs. Srivastava isExperienced. Learn about Amebic Liver Abscess.
- Anaplastic Thyroid CancerMs. Srivastava isExperienced. Learn about Anaplastic Thyroid Cancer.
- CholecystitisMs. Srivastava isExperienced. Learn about Cholecystitis.
- Colorectal CancerMs. Srivastava isExperienced. Learn about Colorectal Cancer.
- Cutaneous Lupus Erythematosus (CLE)Ms. Srivastava isExperienced. Learn about Cutaneous Lupus Erythematosus (CLE).
- Cytomegalic Inclusion DiseaseMs. Srivastava isExperienced. Learn about Cytomegalic Inclusion Disease.
- Cytomegalovirus InfectionMs. Srivastava isExperienced. Learn about Cytomegalovirus Infection.
- DysferlinopathyMs. Srivastava isExperienced. Learn about Dysferlinopathy.
- FibrosarcomaMs. Srivastava isExperienced. Learn about Fibrosarcoma.
- Follicular Thyroid CancerMs. Srivastava isExperienced. Learn about Follicular Thyroid Cancer.
- Gallbladder CancerMs. Srivastava isExperienced. Learn about Gallbladder Cancer.
- Gallbladder DiseaseMs. Srivastava isExperienced. Learn about Gallbladder Disease.
- HeadacheMs. Srivastava isExperienced. Learn about Headache.
- Limb-Girdle Muscular DystrophyMs. Srivastava isExperienced. Learn about Limb-Girdle Muscular Dystrophy.
- MalariaMs. Srivastava isExperienced. Learn about Malaria.
- Metastatic Brain TumorMs. Srivastava isExperienced. Learn about Metastatic Brain Tumor.
- Oral Squamous Cell CarcinomaMs. Srivastava isExperienced. Learn about Oral Squamous Cell Carcinoma.
- Oral Submucous FibrosisMs. Srivastava isExperienced. Learn about Oral Submucous Fibrosis.
- OrchiectomyMs. Srivastava isExperienced. Learn about Orchiectomy.
- PIK3CA-Related Overgrowth SpectrumMs. Srivastava isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Testicular Yolk Sac TumorMs. Srivastava isExperienced. Learn about Testicular Yolk Sac Tumor.
- Tissue BiopsyMs. Srivastava isExperienced. Learn about Tissue Biopsy.